openPR Logo
Press release

Hypoparathyroidism Treatment Market is dominated by top manufacturers and is projected to display a promising CAGR of 8% during 2021-2031

12-06-2021 06:33 PM CET | Health & Medicine

Press release from: Future Market Insights

Hypoparathyroidism is a rare endocrine disorder, which often results in levels of calcium and high levels of phosphate, which in turn results in the production of low or abnormal parathyroid (PTH) levels. According to a recent research report by Future Market Insights (FMI), the hypoparathyroidism treatment market is estimated to reach a valuation of US$ 717.7 Mn in 2021, and is projected to display a promising CAGR of approximately 8% through the end of the forecast period in 2031.

Hypothyroidism primarily arises from surgeries in the neck region. It is associated to accidental damage to the parathyroid gland. High prevalence of these surgeries is expected to boost the demand in the hypoparathyroidism treatment market. For instance, in the U.S., up to 115,000 people are diagnosed with the chronic hypoparathyroidism. The majority of the hypoparathyroidism cases are caused by anterior neck surgery, which accounts for up to 75% of the of all hypoparathyroidism cases. The remaining 25% cases are non-surgical or in very rare cases is linked to genetic disorders.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7857

Furthermore, considering the rare occurrence of this medical condition, hypoparathyroidism has been designated as an orphan disease by the U.S. FDA and European Commission. This designation of orphan disease will help manufacturers to speed up their drug development processes, which leads to better availability of drugs for treatments of hypoparathyroidism.

However, the unprecedented nature of the COVID-19 pandemic has had a significant impact on the development of drugs for rare diseases including those associated with hypoparathyroidism. Preference now is being given to the development of life-savings drugs with greater focus on development of COVID-19 drugs and vaccines, thus halting or suspending existing clinical trials other than live saving drugs.

Also, this has led to the delay or postponement of enrolment of the new participants for clinical studies. Thus, the lack of sufficient data availability on the safety and effectiveness of treatments from clinical trials, will hurt short-term prospects. Clinical trials will gradually resume through 2021, and is anticipated to pick up pace during the forecast period.

Key Takeaways from Hypoparathyroidism Treatment Marker Study

- Calcium supplements dominate the hypoparathyroidism treatment market growing 2x by 2031 owing to efficacy with hormonal therapy.
- Parenteral route of administration is projected to grow at higher pace, driven by a rise in the number of clinical trials, and approval of new drugs which are influencing strong growth in this segment.
- United States holds over 85% of the North America market for hypoparathyroidism treatments and will remain dominant owing to government incentives.
- The U.K. will exhibit high demand, registering y-o-y growth at nearly 7% in 2021.
- Germany and France will emerge as key markets within Europe.
- China and India reflect high potential for growth on the back of a large subclinical patient pool for kidney disorders, diabetes, obesity, thyroid surgeries or head & neck surgery.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-7857

Product Approvals, and Expansion Strategies Gain the Focus of Drug Manufacturers

Prominent players in the hypoparathyroidism treatment market are focusing on receiving approvals and grants for the development of new drugs to cater to the growing cases of hypoparathyroidism, thus, enhancing their market presence. For instance,

- In October 2020, Ascendis’s TransCon PTH was designated as orphan drug by the European commission (EC), which is approved for use to treat hypoparathyroidism in Europe.
- In July 2020, ProLynx, received a Small Business Innovation Research (SIBR) grant from NIH to help fasten the development PTH (1, 34), a long acting parathyroid hormone that can be in a week to patients suffering from hypoparathyroidism.

Key Participant Insights

Prominent players in the hypoparathyroidism treatment market is entering into the strategic agreements and collaborations at regional levels, with special focus on emerging economies. Major players are consolidating their positions through regional collaborations to strengthen their presence and increase their product reach in these countries.

Some of the leading market players covered by FMI in the hypoparathyroidism market include Takeda Pharmaceutical Company Limited., Entera Bio Ltd. Ascendis Pharma A/S, F. Hoffmann-La Roche Ltd, and BionPharma Inc.

Read Full Report - https://www.futuremarketinsights.com/reports/hypoparathyroidism-treatment-market

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypoparathyroidism Treatment Market is dominated by top manufacturers and is projected to display a promising CAGR of 8% during 2021-2031 here

News-ID: 2486874 • Views:

More Releases from Future Market Insights

AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Rising Digital Transformation
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Advanced Technology Integration
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels. As e-commerce continues to penetrate global
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Technological Innovation
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications. The expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Security Infrastructure Expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across

All 5 Releases


More Releases for FMI

Guidewires Market's Journey Ahead: FMI Report Anticipates 6.1% CAGR, US$ 5.9 Bil …
From 2022 to 2030, the global Guidewires Market is projected to develop significantly at a compound annual growth rate of 6.1%, with a market size of over US$ 3.7 Bn in 2022. The market is expanding at a faster rate due to rising demand for straight-tip guidewires for minimally invasive spine and cervical surgeries. According to a new research study by Future Market Insights, -Straight tip guidewires, with a current share of
Ammonium Phosphate Market Share, Size, Trends - 2029 | FMI
The projected growth rate of ammonium phosphate market is approximately 3.3% over the course of forecast period (2019-2029). The demand from fertilizers segment remains steady and even surges in emerging economies. Other end-use industries such as electronics and optics are complementing the growth of ammonium phosphate market. Download Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1469 Key Takeaways of Ammonium Phosphate Market Study • Fertilizers industry accounts for substantial ammonium phosphate demand. • Rising uptake of ammonium phosphate in
Wearable Fitness Trackers Market Forecast & Share 2027 | FMI
The global wearable computing devices market is expected to be worth US$ 37,557 Mn in 2022, rising to US$ 217,237.2 Mn by 2032. The sales of wearable computing devices are expected to grow at a CAGR of 19.2% during 2022-2032. The wearable computing devices market size is expected to increase during the projected period as they assist clinicians in remotely monitoring patient health. Consumer interest in smart fitness gadgets is increasing
Edible Oil Packaging Market Size & Share - 2023 - 2031 | FMI
According to a recent report by Future Market Insight, sales of packaging solutions for edible oil would increase by 1.7 times to reach 3.7 billion units in 2031. In 2021, the market for packaging edible oil is anticipated to expand annually by 4.1%. By 2025, FMI projects that sales of drums will be close to $5 billion. The market for edible oil packaging in the United States is anticipated to
MOPP Packaging Films Market Size, Analysis & Opportunity | FMI
The MOPP packaging films market is projected to register high demand through 2021, with the overall valuation reaching US$ 221.7 Mn in 2021. FMI also forecasts MOPP packaging films demand to increase at a steady 5.2% CAGR between 2021 and 2031. Despite restrictions imposed amid COVID-19, MOPP packaging films demand will surge 2021 onwards, albeit gradually. Volume sold globally is expected to total 135.2 Th. tones by the end of
Labels Market Size, Industry Share, Sales & Trends - 2032 | FMI
The global labels market size is set to reach a valuation of US$ 39.8 Bn in 2022, and further accelerate at a CAGR of 4.8% from 2022-2032. The market is projected to reach US$ 63.7 Bn by the end of 2032. Sales of labels are anticipated to augment with the top 5 players holding 10-15% of the global labels market share in 2021. Based on product type, the pressure sensitive labels